Pharmacy Benefits Managers

Article

In pharmacy, the insurance companies call themselves Pharmacy Benefits Managers (PBM). What do they call themselves over on your corner of the corral?

The ones who are paying, always dictate the rules, always. I know you are aware of this if you are in any of the medical professions. But pharmacy has been so fragmented during the last couple decades that the profession was easy pickin's for the insurance industry. Pharmacists are putting up with $4.00 fees on an $85.00 investment. That is just the average prescription. There are plenty of $4.00 fees on prescriptions costing hundreds of dollars.

In pharmacy, the insurance companies call themselves Pharmacy Benefits Managers (PBM). What do they call themselves over on your corner of the corral? Doctors should be holding all of the cards, but they are also being picked apart piece by piece. You bill a usual and customary of $100.00 and settle for $60.00. Usual and customary is BS. We both know that. By the way, the average wage for a medical doctor has declined almost every year for the past 6-7 years, as of the last time I saw any numbers. It’s all a game of leverage.

PBMs hire some slick clinical pharmacists to justify why they won’t cover certain medicines. Always very expensive medicines. I suppose that the insurance companies hire doctors or very good nurses to argue with you about if they will cover procedures or treatments or diagnostic tests.

How did we ever let this get out of our grasp? The insurance companies provide absolutely no medical care. None. Nada. Zilch. In the end, what the insurance companies do is take in $100.00, keep $25.00 for themselves and pay out the remaining $75.00. They have the leverage. We gave it to them.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.